Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer

Renal cell carcinoma (RCC) is the most common malignant tumor of the urinary system, and it has a high frequency of local invasion and distant metastasis. Although multiple advances have been made in the diagnosis and therapy of RCC, the vast majority of patients with metastatic RCC remain incurable...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Wang, Zhibo, Xie, Lin, Zhang, Yibin, Deng, Tanggang, Li, Jianglin, Liu, Jing, Xiong, Wei, Zhang, Lei, Zhang, Lin, Peng, Bo, He, Leye, Ye, Mao, Hu, Xiaoxiao, Tan, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108068/
https://www.ncbi.nlm.nih.gov/pubmed/30141409
http://dx.doi.org/10.1016/j.omtn.2018.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108068/
https://www.ncbi.nlm.nih.gov/pubmed/30141409
http://dx.doi.org/10.1016/j.omtn.2018.07.015

Ejemplares similares